This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Description, Dosage, Side Effects, Contraindications. Data from EMA, URPL, openFDA and other regulatory sources.
| Salbutamol | Salmeterol | |
|---|---|---|
| Active Substances | Salbutamolum | Salmeterolum |
| ATC Code | R03CC02 | R03AC12 |
| Form | Roztwór do wstrzykiwań | Proszek do inhalacji, podzielony |
| Dosage | 0,5 mg/ml | 50 mcg/dawkę inh. |
| Route | domięśniowa, dożylna, podskórna | wziewna |
| Manufacturer | Zakłady Farmaceutyczne POLPHARMA S.A. | Polfarmex S.A. |
Salbutamol (INN: Salbutamolum, ATC R03CC02) and Salmeterol (INN: Salmeterolum, ATC R03AC12) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.